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Structural basis for potentiation by alcohols and
anaesthetics in a ligand-gated ion channel
Ludovic Sauguet1,2,3,4,*, Rebecca J. Howard5,w,*, Laurie Malherbe1,2,3,4, Ui S. Lee5, Pierre-Jean Corringer3,4,
R. Adron Harris5 & Marc Delarue1,2
Ethanol alters nerve signalling by interacting with proteins in the central nervous system,
particularly pentameric ligand-gated ion channels. A recent series of mutagenesis experi-
ments on Gloeobacter violaceus ligand-gated ion channel, a prokaryotic member of this family,
identified a single-site variant that is potentiated by pharmacologically relevant concentra-
tions of ethanol. Here we determine crystal structures of the ethanol-sensitized variant in the
absence and presence of ethanol and related modulators, which bind in a transmembrane
cavity between channel subunits and may stabilize the open form of the channel. Structural
and mutagenesis studies defined overlapping mechanisms of potentiation by alcohols and
anaesthetics via the inter-subunit cavity. Furthermore, homology modelling show this cavity
to be conserved in human ethanol-sensitive glycine and GABA(A) receptors, and to involve
residues previously shown to influence alcohol and anaesthetic action on these proteins.
These results suggest a common structural basis for ethanol potentiation of an important
class of targets for neurological actions of ethanol.
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S
ince the development of alcoholic fermentation technology
millenia ago, ethanol has been one of the most widely used
drugs in human civilization1. Today, the excessive use of
ethanol imposes a considerable health and economic burden in
many countries; among other things, it is the major global cause
of disability in people 10–24 years of age2. Ethanol is unique
among commonly used drugs in that its molecular sites and
mechanisms of action are poorly defined, mainly owing to the
weak binding energy of this small molecule and the lack of X-ray
structures of alcohol bound to targets relevant for its intoxicating
effects3. Similarities in the chemical and pharmacological profiles
of alcohols and anaesthetics have led to the proposal that these
agents may act via shared sites of action; however, the nature of
these interactions remains unclear.
Studies of neurological actions of alcohols and anaesthetics
have focused on ligand-gated ion channels such as GABA(A),
glycine and nicotinic acetylcholine receptors3. Several of these
receptors are genetically linked to ethanol effects in animals4,5
and humans6, and are modulated by alcohols and anaesthetics
in vitro7–11. Receptors in this family are assembled from five
identical or similar subunits arranged around a C5 symmetry axis
perpendicular to the membrane; each subunit contains a
large ligand-binding extracellular domain, a transmembrane
domain comprised of four helices (M1–M4) from each subunit
and a variable intracellular loop. These receptors carry
neurotransmitter-binding sites within the extracellular domain,
while the ion channel is located in the transmembrane domain.
The coupling of agonist binding and channel opening involves
critical regions between the extracellular and transmembrane
domains, particularly extracellular loops 2 and 7 and the upper
portion of the pore-lining M2 helices12. Mutagenesis and labelling
studies have identified a few specific residues critical to alcohol
and anaesthetic effects, primarily in the transmembrane domain3.
However, in the absence of high-resolution structures of human
ligand-gated ion channels, our understanding of the molecular
effects of these agents remains limited compared with most other
psychoactive drugs.
A remarkable advance in our ability to study alcohol and
anaesthetic modulation was the recent crystallization of ligand-
gated ion channels from lower organisms that are closely related
to mammalian targets of alcohol13–16. The proton-activated G.
violaceus ligand-gated ion channel (GLIC) was crystallized in the
presumed open state17, and has since been determined in an
alternative ‘locally-closed’ conformation18, as well as in complex
with various modulators19,20. In particular, GLIC exhibited
inhibition by general anaesthetics21 similar to nicotinic
acetylcholine receptors9, and we determined its structure in
complex with the anaesthetic agents propofol and desflurane20,
providing insight into the structural basis for drug effects on some
members of this family.
More recently, we found that ethanol potentiates GLIC, though
only at non-pharmacological concentrations22. In the GLIC
structure, amino-acid positions implicated in alcohol modulation
of human ligand-gated ion channels clustered around a set of inter-
and intra-subunit transmembrane cavities22. Moreover,
introduction of the mutation F238A in the pore-lining M2 helix
(F140A in prime notation, counting from the N terminus of M2)
resulted in marked potentiation of function by pharmacologically
relevant concentrations of ethanol22, similar to mammalian
receptors. This ethanol-sensitized variant provides an opportunity
to use structural methods to define the site(s) responsible for
ethanol modulation of this and other ligand-gated ion channels.
In this study, we determined crystal structures of the ethanol-
sensitized GLIC variant in the absence and presence of ethanol
and other modulators. These structures suggested a structural
mechanism for stabilization of the open form of the channel by
alcohols and anaesthetics. Mutations expected to alter modulator
binding confirmed the importance of specific interactions
revealed by the new structures. Multalignments and homology
modelling indicated that a similar mode of binding is likely to
exist in human ethanol-sensitive ligand-gated ion chanels, such as
glycine and GABA(A) receptors.
Results
Crystal structure of a GLIC ethanol-sensitized variant. Previous
studies showed that the F140A mutation in GLIC slightly reduces
proton sensitivity (shifting EC50 from pH 4.9 to pH 4.3) and
dramatically enhances ethanol sensitivity, conferring potentiation
by pharmacologically relevant (20mM) concentrations of etha-
nol22. To investigate the structural basis for these changes, the
structure of the ethanol-sensitized GLIC mutant F140A was
determined at 2.75Å (Supplementary Table S1) under
crystallization conditions similar to those used in previous
structures of wild-type GLIC (Fig. 1a)14. The mutant structure
(Fig. 1b) was similar to that of the wild-type protein, with a root
mean square deviation of 0.22Å over the 1,555 Ca atoms. The
principal structural difference was in the region of the 140 residue,
which in wild-type GLIC forms one end of a transmembrane
cavity at the interface between channel subunits20 (Fig. 1a). In the
mutant structure, the absence of the phenyl ring at 140 was
associated with an expanded inter-subunit cavity, penetrating one
to two registers deeper into the membrane-spanning region. The
volume of the cavity was increased by 267Å3. This cavity was
relatively polar and likely to be hydrated; indeed, electron density
for at least one water molecule was well resolved (Fig. 1b). The
mutation also appeared to increase structural flexibility, as
indicated by high B-factors throughout the structure (99.5 Å2)
(Fig. 1b) relative to the wild-type (69.6 Å2) (Fig. 1a). Although
many reasons could account for the B-factor deviations observed
between the GLIC F140A and wild-type structures, several
observations suggest that these differences are specifically
caused by the F140A mutation: (1) Both proteins crystallize in
the same space group, display identical unit cell dimensions and
both structures were solved at similar resolutions. (2) The
B-factor deviations were not homogeneously distributed over the
protein; instead, they were concentrated in the transmembrane
domain, especially in regions neighbouring the inter-subunit
transmembrane cavity, including the extracellular portion of M2
and pre-M1. Deviations in B-factors were also observed in loops
2, 7 and F, connecting the extracellular to the transmembrane
domains (Supplementary Fig. S1). (3) The most affected region by
the F140A mutation lies about 35Å from the closest crystal
contact suggesting that the B-factor deviations are not owing to
lattice disorders. (4) This structural destabilization of the
presumed open conformation of GLIC might also explain the
reduced proton sensitivity observed for this mutant22.
Structures of the GLIC F140A variant bound to alcohols. We
then grew crystals of the GLIC F140A variant in the presence of
ethanol, and determined the structure to 2.80Å (Supplementary
Table S1). The ethanol-bound structure (Fig. 1c) was completely
superimposable with the apo-form of F140A, except for a strong
Fo–Fc electron density peak in each of the expanded inter-sub-
unit cavities (7.6±0.8s over all five monomers) (Figs 2a and 3a
and Supplementary Fig. S2a).
Identifying the position and orientation of ethanol by X-ray
crystallography is particularly challenging owing to its small size,
lack of distinguishing structural features and weak binding
energy. Therefore, in order to confirm the presence and structure
of ethanol in the electron density, we repeated the experiment
using 2-bromoethanol, an analogue of ethanol containing a
bromine atom that produces a specific anomalous signal that can
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be observed by crystallography using X-rays with tunable wave-
lengths. A 3.05 Å structure (Supplementary Table S1) of GLIC
F140A co-crystallized with 2-bromoethanol contained the same
peak in the Fo–Fc electron density, as well as a strong bromine
anomalous signal (5.4±0.5s over all five monomers) over-
lapping the most buried portion of the peak (Figs 2b and 3a,
Supplementary Fig. S2b). We therefore assigned the inter-subunit
density to one ethanol molecule per subunit, each oriented with
its aliphatic chain buried in the cavity, and its hydroxyl group
facing towards the transmembrane/extracellular domain interface
(Fig. 3b). The inter-subunit ethanol-binding cavity was distinct
from the intra-subunit cavity previously shown to bind inhibitory
anaesthetics20 in wild-type GLIC. In addition, the presence of a
weak intra-subunit bromine anomalous signal in the co-crystal
structure with 2-bromoethanol supported the possibility that
alcohols may also bind there, but with too low occupancy or
too high mobility to allow for confident model building
(Supplementary Figs S2a, S2b).
Co-crystallization with ethanol appeared to stabilize the F140A
structure, resulting in decreased overall B-factors (85.5 Å2) with a
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distribution that resembled wild-type GLIC (Fig. 1c and
Supplementary Fig. S1). Given that GLIC was crystallized under
activating conditions (pH 4.0), has a pore wide enough to conduct
ions17, and corresponds to other recent open structures of ligand-
gated ion channels16, the decrease in B-factors upon ethanol
binding would be consistent with a macroscopic role for the drug
in stabilizing the open state of the channel. Nevertheless, other
experiments will be necessary to formally demonstrate that point.
The structural data suggest that ethanol potentiates the GLIC
F140A mutant by binding to the expanded inter-subunit cavity. In
order to test this hypothesis, we performed site-directed
mutagenesis of residues bordering the ethanol-binding pocket
that was observed by crystallography.
Mapping the ethanol-binding site by site-directed mutagenesis.
Ethanol binding was mediated by hydrophobic and hydrophilic
interactions. The closest hydrophobic contacts of the aliphatic
chain were with residue I160 in the M2 helix of one subunit and
L170 in M2 of the neighbouring subunit (Fig. 3b). Substituting
phenylalanine at either of these positions compensated for
reduced proton sensitivity of the F140A variant (Fig. 3c) and
reduced the effect of F140A on modulation by both ethanol
(Fig. 3d,e) and 2-bromoethanol (Fig. 3f): L170F reduced poten-
tiation more than fivefold, while I160F blocked potentiation
entirely, resulting in a channel similar to wild-type GLIC.
Our co-crystal structure also revealed three possible hydrogen
bonds with the ethanol hydroxyl group (Fig. 3b). Owing to a
conserved proline in the nþ 4 position23, the carbonyl oxygen of
M1 residue N200 is kinked towards the inter-subunit cavity, and
is in a position to accept a hydrogen bond from ethanol in the co-
crystal structure or from water in the apo-structures. The ethanol
hydroxyl group also borders the M2 residue N150, which could
donate or accept a hydrogen bond, and which aligns with the
most critical residue for alcohol potentiation of GABA(A) and
glycine receptors24. Disrupting hydrogen bonding by substituting
alanine at N150 in the context of F140A compensated for reduced
proton sensitivity (Fig. 3c) and decreased potentiation by ethanol
(Fig. 3d,e) and 2-bromoethanol (Fig. 3f), consistent with a role for
this interaction in stabilizing alcohol binding and modulation.
We also tested a potential hydrogen bond with residue E190 at the
extracellular end of the inter-subunit cavity. As the double
mutant F140A/E190A was non-functional, we characterized the
triple mutant F140A/N150A/E190A, in which disruption of the
E190 interaction did not further decrease ethanol (Fig. 3e) nor
2-bromoethanol (Fig. 3f) potentiation, compared with F140A/
N150A. Thus, the N150 interaction appeared to be particularly
critical for alcohol binding. Polar interactions at this site may be
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Figure 3 | Alcohol binding to ethanol-sensitized GLIC. (a) Left,
extracellular view of full transmembrane domain showing the sigma-A-
averaged 2Fo–Fc electron density map (blue) contoured at 1.0s
surrounding the refined position of ethanol (orange). Top right, equivalent
density relative to contiguous transmembrane cavities (white) associated
with one subunit interface. Bottom right, same representation for GLIC
F140A co-crystallized with 2-bromoethanol. The 2Fo–Fc electron density
(blue) is overlaid with bromine-specific anomalous map (magenta)
contoured at 5.0s. All maps are pictured within 2Å of the modelled
ligands. (b) Inter-subunit interface of F140A plus ethanol, showing M1–M2
(dark grey) and M2–M3 (light grey) from neighbouring subunits, backbone
and side-chain atoms for interfacial 140 residue, and all amino acids within
4Å of ethanol. Dashes indicate three possible hydrogen bonds. Residue
N200 neighbours ethanol via its backbone carbonyl, and only its backbone
is shown. (c) Proton response curves for GLIC wild-type (black), F140A
(orange) and F140A-containing mutants I160F (green), L170F (yellow), N150A
(pink) and N150A/E190A (purple). Dashes indicate EC10. (d) Sample traces
showing EC10 activations (H
þ ) of GLIC F140A, F140A/I160F and F140A/
N150A in the absence and presence of 200mM ethanol (E). Scale bars:
500nA, 2min. (e) Modulation by 200mM ethanol of GLIC currents;
n¼ 5–16. (f) Modulation by 60mM 2-bromoethanol, shown as in f; n¼4–5.
In f and g, bracket represents two-tailed unpaired t-test, not significant
(NS); all other comparisons indicate analysis of variance, Dunnett’s test
significance versus F140A; ***Po0.001.
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important, given that a water molecule was resolved in the
equivalent region of the GLIC F140A apo-structure (Fig. 1b).
Overlapping binding of general anaesthetics. To better under-
stand the mechanism for allosteric modulation by alcohols and
related anaesthetic agents, we determined additional crystal
structures (Supplementary Table S1) of the volatile anaesthetic
bromoform bound to both wild-type GLIC (Fig. 4a) and the
ethanol-sensitized variant (Fig. 4b). Bromoform is a structural
analogue of chloroform, in which the chlorine atoms are sub-
stituted by bromine, thereby producing a specific anomalous
signal that allows the unambiguous localization of the molecule in
the electron density. Like other volatile anaesthetics21,
bromoform inhibited wild-type GLIC (Fig. 4c); the current
work confirms and extends, by making use of a higher resolution
and the bromine-specific anomalous signal (Fig. 4a and
Supplementary Fig. S2d), the earlier observation of propofol
and desflurane20 binding into the intra-subunit cavity. Indeed,
this higher-resolution structure reveals that bromoform occupy
alternatively three poses in the intra-subunit cavity, including two
poses close to the original ones. The first two poses of bromoform
were modelled and refined as alternative conformations of the
same bromoform molecule. The third pose has a markedly lower
occupation and anomalous signal.
The F140A mutation converted bromoform into a potentiator,
as with long-chain alcohols22 (Fig. 4c). In this case, bromoform
was found to bind not only to the previously known intra-subunit
cavity but also to the inter-subunit cavity described here for
ethanol (Fig. 4b,e, Supplementary Fig. S2c). In addition, the
crystal structure reveals that bromoform adopts different
‘binding-modes’ in the intra- and inter-subunit cavities. In the
intra-subunit cavity, bromoform displays a substantial mobility
and occupies alternatively different poses. This is reminiscent of
previously published functional and structural data that suggested
a significant mobility of propofol and desflurane in this cavity20.
In the inter-subunit cavity, the volume and shape of the cavity
imposes one pose for bromoform, which was refined with a full
occupancy. Interestingly, binding of bromoform to the F140A
ethanol-sensitized mutant produced the same macroscopic-
stabilizing effect on the B-factor distribution that was observed
for the ethanol-bound structure (data not shown). As for ethanol,
these results suggest that potentiation by bromoform of the GLIC
ethanol-sensitized mutant occurs through binding in the inter-
subunit cavity of the open channel.
Phenylalanine substitutions in the inter-subunit site blocked
potentiation of the GLIC variant by bromoform (Fig. 4c),
indicating that the anaesthetic and alcohols occupied
overlapping potentiating sites. A similar pattern was observed
for propofol inhibition, which was blocked by the F140A mutation
and restored by phenylalanine substitutions in the inter-subunit
site (Fig. 4d).
Interestingly, while the hydrophilic N150 interaction was critical
for ethanol potentiation, substituting alanine at this residue
further enhanced potentiation by bromoform (Fig. 4c) and
propofol (Fig. 4d). This pattern is consistent with the
hydrophobic nature of anaesthetics, including bromoform and
propofol, relative to ethanol, such that they may depend more
heavily on van der Waals interactions within the protein-binding
site. These observations support an overlapping but chemically
distinct mechanism of allostery by anaesthetics compared with
alcohol.
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Figure 4 | Bromoform binding to wild-type and ethanol-sensitized GLIC. Bromine-specific anomalous map contoured at 5.0s (magenta) and sigma-
A-averaged 2Fo–Fc electron density map (blue) assigned to bromoform (green) relative to the contiguous intra- and inter-subunit transmembrane cavities
(white) associated with one subunit interface of wild-type GLIC (a) and the ethanol-sensitized GLIC variant (F140A) (b). The anomalous and 2Fo–Fc maps
are, respectively, pictured within 4 and 2Å of the modelled ligands. (c) Modulation by 1mM bromoform of GLIC wild-type (black), F140A (orange),
and F140A-containing mutants I160F (green), L170F (yellow) and N150A (pink); left axis broken for clarity; n¼ 5–8. (d) Modulation by 100mM propofol of
GLIC variants as in c; n¼ 5–11. In c and d, bracket represents significant difference between GLIC F140A and F140A/N150A measured by two-tailed unpaired
t-test; all other comparisons indicate analysis of variance, Dunnett’s test significance versus F140A; *Po0.05, **Po0.01, ***Po0.001. (e) The intra-
(green) and inter-subunit (blue) cavities associated with a single-subunit interface from the indicated co-crystal structure. Inset structures represent wild-
type GLIC co-crystallized with inhibitory anaesthetics, which overlap the previously described propofol- (orange) and desflurane (pink)-binding sites20.
Inter-subunit sites (blue) associated with receptor potentiation. Insets represent GLIC F140A structures crystallized with potentiating agents.
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Discussion
Ethanol has been co-crystallized as a solvent or cofactor in several
other published protein structures, including mammalian alcohol
dehydrogenase as early as 1994 (ref. 25). Among proteins
implicated in neurological effects of ethanol, structural
information has been limited to the Drosophila protein LUSH26
(not observed in humans), although a larger alcohol was co-
crystallized with the isolated cytoplasmic domain of an inwardly
rectifying potassium channel (IRK1)27. In the apo form, LUSH
displays conformational flexibility, but is rigidified upon binding
of alcohols via a central hydrophobic pocket of the protein, as
demonstrated by peak narrowing in NMR spectra26. Consistent
with the types of molecular interactions observed in LUSH26 and
IRK1 (ref. 27), ethanol interacted with the GLIC variant via
multiple hydrophobic contacts and at least one hydrogen bond.
Although other experiments will be necessary to further
document that point, the crystal structure suggests that ethanol
binding to the GLIC ethanol-sensitive mutant stabilizes the open
conformation of the channel as indicated by a marked decrease of
B-factors within the region of the ethanol-binding pocket.
Our structural data showed that potentiation by alcohol and
anaesthetics occurrs upon binding into an inter-subunit cavity in
GLIC F140A, directly stabilizing the open state of the channel.
This observation is supported by site-directed mutagenesis
experiments based on the GLIC F140A structures, revealing that
phenylalanine substitutions at either the 160 or 170 positions (both
proximal to the ethyl carbons of ethanol) blocked the inter-
subunit cavity and disrupted potentiating interactions with
ethanol and general anaesthetics. Moreover, both substitutions
enhanced proton sensitivity, reflecting that channel opening is
facilitated by decreased volume and/or increased hydrophobic
contacts in the inter-subunit cavity18. Substitution of alanine at
N150 could also increase hydrophobic interactions at the subunit
interface, resulting in a similarly decreased EC50 for proton.
Notably, these results suggest that the mechanism of open state
stabilization via mutations is at least partially shared with that
of alcohol potentiation. Previous cysteine labelling at positions
170–190 appeared to mimic ethanol potentiation22 further
supporting a model in which occupation of the inter-subunit
pocket promotes channel opening in GLIC (ref. 18).
This study also confirmed that alcohols and anaesthetics share
sites of action on ligand-gated ion channels. Indeed, resolution of
the volatile anaesthetic bromoform in the inter-subunit cavity of
GLIC F140A—overlapping the position of ethanol and relying to a
similar extent on the hydrophobic 160 and 170 residues—indicated
that the enhanced inter-subunit ethanol-binding site also
facilitated an inter-subunit-binding mode for anaesthetics.
Notably, bromoform has no hydroxyl moiety, and was therefore
incapable of hydrogen bonding with the 150 residue; generally,
hydrophobic interactions are likely to have a bigger role in
anaesthetic binding versus alcohols, which may rely more on
hydrogen bonding. This distinction may explain the opposite
effects of the N150A mutation on alcohol versus anaesthetic
modulation: loss of the N150 hydrogen bond correlated with
reduced alcohol potentiation, whereas the nonpolar residue
substitution here increased anaesthetic potentiation. Our data
suggest that binding of anaesthetics and alcohols may be
structurally overlapping, yet chemically distinct.
Combined structural and mutational data strongly support that
the inter-subunit cavity mediates the potentiating effects of
ethanol and anaesthetics. Our previous structural studies suggest
that the intra-subunit cavity is important for inhibition of
channel function20. However, binding of anaesthetics to the intra-
subunit cavity was observed in the structure of the open form of
the channel, whereas anaesthetics are expected to stabilize a
closed form. One possibility is that this intra-subunit cavity is
remodelled upon the transition towards a closed form of the
channel so that the anaesthetics can bind more strongly to the
closed form than to the open form. In support of this idea, recent
results from a photoreactive activable propofol analogue suggest
that propofol binds to a similar inhibitory intra-subunit cavity
preferentially in a desensitized closed form of the nicotinic
acetylcholine receptor28. Definitive characterization of channel
inhibition mechanisms will likely require determination of high-
resolution co-crystal structures of the closed channel bounds to
anaesthetics.
The novel potentiating site identified in the GLIC variant
structure occupies a pivotal location for gating at the interface of
TMD subunits and ECD–TMD domains. Moreover, this pocket
contacts the extracellular half of the M2 helices; this region was
shown to have a key role in gating in the recently determined
non-conductive state of GLIC, which displayed a conserved
alternative conformation in M2 and an expanded inter-subunit
cavity18. This potentiating site also overlaps the allosteric agonist
ivermectin in recent structures of the Caenorhabditis elegans
glutamate-gated chloride channel16. However, ivermectin binding
produces a local displacement of the M1 and M3 transmembrane
helices within the three-dimensional structure, while in our case
ethanol binding preserves the conformation intact but apparently
provides energetic stabilization. These data thus suggest an
overlapping inter-subunit location, but different mechanisms for
stabilizing the open state of ligand-gated ion channels by the
small (46Da) ethanol and the relatively large (875Da) ivermectin
molecules.
The GLIC F140A variant is a structural and functional
homologue of known neurological targets of alcohol and
anaesthetics, particularly GABA(A) and glycine receptors, which
mediate fast inhibitory neurotransmission in the brain and spinal
cord. Ethanol enhances the depressant effects of both GABA
(ref. 29) and glycine30 in mice, and genetic studies support the
involvement of GABA(A) and glycine receptors in behavioural
effects of ethanol in animals4. In addition, the a2 and g1 subtypes
of GABA(A) receptors are associated with genetic risk for alcohol
dependence in humans6. In heterologous expression systems,
some members of these receptor families are potentiated by 30–
100mM ethanol, concentrations that produce moderate to severe
intoxication in humans3. A similar range of approaches identified
GABA(A) and glycine receptors as substrates for general
anaesthetics11. In most cases, anaesthetics resemble ethanol in
potentiating GABA(A) and glycine receptor function, including
volatile and injected anaesthetics and a wide range of n-
alcohols7,8,10. Molecular studies have proposed extracellular31,32,
intracellular33 and transmembrane24 sites of action for alcohols
and anaesthetics in GABA(A) and glycine receptors. Our work
supports the proposed transmembrane mechanism, as we
observed ethanol binding exclusively in this region; this is
consistent with previous studies of a GLIC/glycine receptor
chimera that demonstrated that the transmembrane domain is
sufficient to confer alcohol and anaesthetic modulation
properties34.
Superposition of the ethanol-binding pocket identified in our
study onto a homology model of the human a1 glycine receptor35
revealed a large inter-subunit cavity capable of accommodating
ethanol (Fig. 5b). Striking similarities are observed between both
receptors, including conservation of an unbonded backbone
carbonyl in M1 and of polar residues at both the 150 and 190
putative hydrogen-bonding side chains (Fig. 5a). Furthermore,
hydrophobic contacts limiting the size of the inter-subunit cavity
in the GLIC variant (I160 and L170) were absent in the glycine
receptor model (S160 and G170) (Fig. 5b), suggesting a structural
basis for sensitivity of glycine receptors to potentiation by larger
alcohols7. Indeed, sequence alignments indicated that all four
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residues implicated in ethanol action in this study—positions
140–170—are smaller and, in several cases, more hydrophilic in
GABA(A) and glycine receptors than in wild-type GLIC, and
could account for the greater ethanol sensitivity and higher cutoff
for n-alcohol potentiation exhibited by these human receptors7,8
relative to GLIC22. Recent molecular dynamic simulations also
illustrated spontaneous interactions of ethanol with the inter-
subunit cavity of a glycine receptor homology model36, consistent
with our more recent results with GLIC F140A and supporting the
generalizability of this model system to human inhibitory
receptors.
Our results with GLIC F140A are consistent with specific
amino-acid interactions previously shown to control allosteric
modulation of GABA(A) and glycine receptors. Past studies noted
that bulkier substitutions at the 140 position of b2 GABA(A)
receptors37 and a1 glycine receptors35 reduced anaesthetic and
ethanol sensitivity, respectively. Photo-labelling experiments
localized an etomidate photo-reactive analogue-binding site in a
cavity located at the transmembrane interface between
subunits38. Moreover, the 150 residues in both receptor families
were found to be critical for alcohol and anaesthetic
modulation24,39, echoing our structural and functional evidence
for a critical hydrogen bond between ethanol and the 150 residue
in GLIC F140A.
In contrast to the GLIC F140A variant, wild-type GLIC
functional properties resemble several aspects of nicotinic
acetylcholine receptors, which have an excitatory role in
neurotransmission and modulation. Evidence for alcohol action
at nicotinic receptors includes cross-tolerance and twin studies
linking it to nicotine use, as well as genetic changes in the
neuronal (a4b2) nicotinic receptor that influence behavioural
effects of ethanol5. At the physiological level, ethanol potentiates
a4b2 nicotinic currents in cortical and heterologous cell systems;
however, these receptors were inhibited rather than potentiated
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Figure 5 | Alignment of GLIC F140A with human alcohol targets. (a) Sequence alignment of GLIC M1–M3 helices with human ethanol-sensitive
ligand-gated ion channels. M2 residues 140, 150, 160 , 170 and 190 coloured as in Fig. 2b; carbonyl of M1 residue equivalent to GLIC N200 (grey) is available to
interact with solvent owing to a conserved proline in the nþ4 position. Receptors above dashes exhibit high ethanol sensitivity and/or longer cutoffs
for n-alcohol potentiation; receptors below exhibit limited ethanol sensitivity and inhibition by long-chain n-alcohols. (b) View as in Fig. 2b of a human a1
glycine receptor (GlyRa1) homology model based on GLIC (PDB ID 3EAM) as previously described35, with ethanol as in the F140A co-crystal structure.
Ribbons represent M1–M2 (dark grey) and M2–M3 (light grey) from neighbouring subunits. Amino acids within 4Å of superimposed ethanol
molecule (Q226, M227, T120, Q140 , S150, S160 and R190), as well as G170, are shown as balls-and-sticks. Only backbone atoms of Q226 (equivalent to GLIC
N200) are shown. Backbone and side-chain atoms for residues S150 and G170 are shown for clarity. (c) View as in Fig. 2a of a model of the human
a4b2 nicotinic acetylcholine receptor, generated by superimposing human a4 (PDB ID 2LLY) and b2 (PDB ID 2LM2) nicotinic acetylcholine receptor
subunits on the GLIC F140A ethanol co-crystal structure backbone. Amino acids within 4Å of the superimposed ethanol molecule (F140, L150and L170),
as well as L160 , S190 , and backbone atoms of residue N223 (equivalent to GLIC N200), are shown as balls-and-sticks.
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by long-chain n-alcohols and general anaesthetics9—a pattern
similar to wild-type GLIC, with a slightly higher n-alcohol cutoff
for potentiation22.
Superimposing a4b2 nicotinic acetylcholine receptor subunits
from recent NMR structures40 on the GLIC F140A backbone
revealed a cluster of large hydrophobic residues surrounding the
inter-subunit cavity (Fig. 5c). In particular, the F140 residue from
wild-type GLIC is conserved in nicotinic receptor subunits, and
the N150 hydrogen bond partner is replaced by L150 (Fig. 5c).
Previous studies showed that the 150 residue does not mediate
ethanol potentiation in nicotinic receptors; instead, the 160 and
170 residues influence alcohol inhibition and potentiation,
respectively41. Thus, amino-acid variations may produce a
smaller, more hydrophobic inter-subunit cavity in nicotinic
versus GABA(A) and glycine receptors, and could account for
their lower cutoff for n-alcohol potentiation9.
In conclusion, this work provides novel structural and
functional insights into the potentiation by alcohols and
anaesthetics of a ligand-gated ion channel. Examination of
sequence data in a structural framework suggest that there is a
common mode of action for human receptors, thus opening the
way to the rational design of novel allosteric modulators of
members of this family of cys-loop receptors.
Methods
Reagents. Chemicals were purchased from Sigma-Aldrich. The bromoform test
condition was chosen as the concentration required to inhibit wild-type GLIC
currents by B50%, and was equal to the anaesthetic dose (minimum alveolar
concentration required to eliminate response to a noxious stimulus in 50% of
subjects, derived as previously described42) of its analogue, chloroform, adjusted to
deliver the reported concentration calibrated by gas chromatography43. At the time
of application, the adjusted bromoform volume was added via positive
displacement pipette to the appropriate Ringer’s buffer in a scintillation vial with
minimal head space, immediately sealed with parafilm and aluminium foil, and
sonicated for Z2min. The solution was applied by piercing the seal with the
perfusion input needle, minimizing exposure of the solution surface to atmosphere.
Propofol was prepared as 100mM stock solution in dimethyl sulphoxide and used
at 1000 dilution afterZ2-min sonication. All modulators were diluted into fresh
Ringer’s buffer at the time of electrophysiology.
Protein expression and purification. For crystallization, GLIC wild-type and
F140A variant were produced and purified as previously described18,22. Fractions
corresponding to the predicted size of the pentameric protein were pooled and
concentrated for crystallization. The GLIC F140A variant behaved like the wild-
type protein throughout the purification. For electrophysiology, expression
plasmids containing wild-type GLIC in the pMT3 vector were prepared as
previously described44. Mutagenesis was carried out using the QuikChange II site-
directed mutagenesis kit (Agilent) using commercially made mutagenic primers
(IDT). Mutant complementary DNA was confirmed by automated fluorescent
DNA sequencing.
Protein crystallization. GLIC wild-type and F140A variant were crystallized using
vapour diffusion in hanging drops at 20 C. The concentrated (8–12mgml 1)
protein was mixed in a 1:1 ratio with reservoir solution containing typically
12–16% PEG 4000, 400mM NaSCN and 0.1M NaAc pH 4.0. Crystals appeared
overnight in a parallepiped-like shape and grew for 1 week before reaching their
final dimensions (typically 200mm 200 mm 100 mm). Co-crystal structures were
obtained by growing crystals in 200mM ethanol, 200mM 2-bromoethanol or 2%
w/v bromoform. All crystals were cryoprotected using 20% glycerol and flash-
frozen in liquid nitrogen.
Crystallographic data collection. All data sets were collected on beamline
Proxima-I of the Soleil Synchrotron. For the crystals grown in complex with
2-bromoethanol and bromoform, data sets were collected at the peak wavelength of
bromine (0.9191Å), using the inversed-beam strategy in order to optimize the
anomalous signal. For each structure presented in this work, ligand-binding sites
deduced from a minimum of three different crystals diffracting at similar resolu-
tion were identical, supporting the reproducibility of these results. Reflections were
integrated using XDS45 and further analysed using the CCP4 programs46. Mutant
and co-crystals were isomorphous to wild-type in the C2 space group with one
pentamer in the asymmetric unit. Data collection statistics are summarized in
Supplementary Table S1.
Phasing and refinement. The structure of GLIC (PDB ID 3HFI) served as a
starting model that was improved by alternate cycles of manual building in
COOT47 and refinement using REFMAC48 and BUSTER (Global Phasing Ltd.).
Ligand-binding sites were unambiguously identified in the electron density using
the bromine-specific anomalous signal produced by the brominated ligands
(Supplementary Fig. S2). All ligands were refined with a full occupancy except for
the three alternative binding sites of bromoform in the intra-subunit cavity, which
were built with a partial occupancy that was refined in BUSTER. B-factors of 2-
bromo-ethanol and bromoform deviated significantly from the protein B-factors
(Supplementary Table S1). Such B-factor deviation was already observed in other
anaesthetic-bound structures of GLIC20 and accounted for by a substantial
mobility of these molecules that interact predominantly with the protein through
hydrophobic contacts. In addition, high B-factors could also be owing to a partial
loss of occupancy that occurred during data collection following bromine–carbon
bond cleavage owing to irradiation damage, event though the effect of radiation
damage was limited in our experiments by using an inversed-beam strategy for data
collection. Non-crystallographic symmetry restraints and one translation libration
screw parameter per protein chain were used throughout the refinement. Among
the refined protein residues, 97.9–98.6% were in the most favoured regions of the
Ramachandran plot, with 0% outliers. MolProbity scores49 for the refined models
all ranged within the 100th percentiles of structures refined at comparable
resolutions. Details of the refinement statistics are provided in Supplementary
Table S1. We noted that 72 atoms corresponding to six detergent molecules
resolved in the pore of wild-type GLIC were not observed in the F140A mutant
structure, possibly owing to the increased protein motion in this region indicated
by increased B-factors. Pore density attributed to detergent molecules was restored
in co-crystal structures with ethanol, 2-bromoethanol and bromoform, consistent
with overall stabilization of the mutant channel pore region in the presence of
allosteric modulators.
Oocyte preparation. Extraction of ovarian tissue from Xenopus laevis frogs was in
accordance with the National Institutes of Health guide for the care and use of
laboratory animals. Tissue was placed in Modified Barth’s Solution containing
88mM NaCl, 10mM HEPES, 2.4mM NaHCO3, 1mM KCl, 0.91mM CaCl2,
0.82mM MgSO4 and 0.33mM Ca(NO3)2, adjusted to pH 7.5. After manual
isolation with forceps, oocytes were treated with collagenase type 1A solution
containing 0.5mgml 1 collagenase, 83mM NaCl, 5mM HEPES, 2mM KCl and
1mM MgCl2, adjusted to pH 7.5 for 10min. Oocyte nuclei were injected via the
animal pole with GLIC wild-type or mutant cDNA using a Nanoject II micro-
dispenser (Drummond Scientific). Injected oocytes were singly stored at 13 C in
Modified Barth’s Solution supplemented with 220mg l 1 sodium pyruvate,
90mg l 1 theophylline, 50mg l 1 gentamicin, 10mg l 1 streptomycin and
10,000U l 1 penicillin for 2–17 days.
Electrophysiology. Oocytes were placed in chambers (B100ml volume) and
perfused (2.0mlmin 1) with Ringer’s buffer (123mM NaCl, 10mM HEPES,
2mM KCl, 2mM MgSO4 and 2mM CaCl2) using a peristaltic pump through
18-gauge Teflon and Viton tubing (Cole-Parmer). Oocytes were impaled with two
glass electrodes filled with 3M KCl and clamped at  70mV using an OC-725C
oocyte clamp (Warner Instruments). Currents were digitized and continuously
plotted using the PowerLab 4/30 data acquisition system (AD Instruments). To
activate GLIC currents, low-pH Ringer’s buffer was applied in which HEPES was
replaced either with 10mM citrate (pH 3.5–6.0) or 10mM MOPS (pH 6.5–7.0).
Proton activation curves (Fig. 2c) represent nonlinear regression fits to the equa-
tion R¼Rmax/(1þ 10 ^ {[log(EC50 P)] nH}), where R is the peak channel
response, Rmax is the maximal response, P is the concentration of protons, EC50 is
the concentration producing 50% maximal response and nH is the Hill coefficient.
Data for each receptor were normalized to its fitted maximal response. To correct
for effects on channel gating, we calculated the B10% activation level of each
mutant and used the corresponding pH to measure modulation. To quantify
modulation, oocytes were treated for 1min with low-pH Ringer’s buffer; after
5-min washout, the alcohol or anaesthetic solution was applied in neutral Ringer’s
buffer for 1min, then in low-pH buffer for 1min; after another 5-min washout,
low-pH buffer was again applied alone. Percentage modulation was calculated as
[(RAR0,R1) / R0,R1] 100, where RA represents the channel response in the
presence of modulator and R0,R1 represents the mean of the pre- and post-
modulator responses. Results were analysed with one-way analysis of variance
and Dunnet’s post hoc test or by two-tailed unpaired t-test as appropriate, with
significant effects set at Po0.05.
Molecular modelling and visualization. Figures were made using PyMol
(Schro¨dinger) or UCSF Chimera50. Surface and size of the cavities were calculated
using the Hollow script51. A homology model of the a1 glycine receptor (Fig. 3b)
was built as previously described35 by threading, refinement and molecular
dynamics on the backbone of wild-type GLIC (PDB ID 3EAM)14 using the
Modeler module of Discovery Studio 2.5 (Accelrys), and aligned to the GLIC
F140Aþ ethanol co-crystal structure using the ‘match’ command in Chimera to
perform least-squares fitting of all backbone atoms. The a4b2 nicotinic
acetylcholine receptor (Fig. 3c) was roughly modelled using the ‘match’ command
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in Chimera to perform least-squares fitting of backbone atoms in M1(222–236)
and M2(10–190) of a representative structure of the a4 nicotinic acetylcholine
receptor subunit (PDB ID 2LLY)40 to M1(199–213) and M2(10–190) in the B chain
of the GLIC F140A structure determined in the presence of ethanol (PDB ID
4HFE), and of M2(10–190) and M3(275–295) of a representative structure of the b2
subunit (PDB ID 2LM2)40 to M2(10–190) and M3(258–278) in the C chain of GLIC
F140Aþ ethanol. As the determination of the nicotinic acetylcholine receptor
subunit structures as monomers leaves substantial uncertainty about the packing of
adjacent subunits, we limited our interpretation of this model to comparison of
properties of directly aligned residues.
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